Prenatal Testing & Newborn Screening Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the Prenatal Testing & Newborn Screening Market Size from 2025 to 2034?
In recent times, the market size for prenatal testing & newborn screening has experienced a swift expansion. There will be a growth from $6.24 billion in 2024 to $6.98 billion in 2025, representing a compound annual growth rate (CAGR) of 11.8%. This growth during the historical period is the result of advancements in genetic testing, escalation in maternal age, elevated awareness and education, along with healthcare policy and regulations.
In the coming years, a swift expansion is predicted in the prenatal testing & newborn screening market. The market is forecasted to reach a value of$10.99 billion in 2029, expanding at a compound annual growth rate (CAGR) of 12.0%. Factors such as genetic counseling, cutting-edge technology, point-of-care testing, telehealth and remote monitoring are leading the growth in the forecast period. Key trends for this period include non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, hemoglobinopathies, and sickle cell screening.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp
What External and Internal Drivers Are Contributing to the Growth of thePrenatal Testing & Newborn Screening Market?
The escalation in the occurrences of genetic illnesses in infants has fostered the expansion of the prenatal testing & newborn screening market. Diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease are included in genetic diseases as per the World Health Organization. Sickle cell anemia, a genetic disease, is widespread, affecting millions globally, especially those with ancestors from Africa, America, Cuba, Central America, Saudi Arabia, and India. A study undertaken at Rady Children’s Hospital by the US-based Rady Children’s Institute for Genomic Medicine, in February 2023, highlighted that 41% of infant fatalities were due to single-locus (Mendelian) genetic diseases. This significant rate of genetic diseases in infants has driven the demand for growth in the prenatal testing and newborn screening market.
What Segment Types Define the Prenatal Testing & Newborn Screening Market Structure?
The prenatal testing & newborn screeningmarket covered in this report is segmented –
1) By Diagnostic Type: Non-Invasive; Invasive
2) By Technology: Screening Technology; Diagnostic Technology
3) By End user: Hospitals; Diagnostic centers
Subsegments:
1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening
2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Prenatal Testing & Newborn Screening Market?
North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Long-Term Trends Are Transforming the Competitive Landscape of the Prenatal Testing & Newborn Screening Market?
Leading firms engaged in the prenatal testing & neonatal screening market are concentrating on launching innovative systems that use rWGS (rapid Whole Genome Sequencing) technology for swift and precise detection of genetic disorders in newborns, thereby facilitating early detection and intervention for better health outcomes. rWGS technology is a state-of-the-art genomic method that instantaneously sequences the whole genome of a person. It is different from conventional genetic testing techniques that focus on distinct genes or regions as rWGS identifies all DNA in a person’s genome to recognize genetic discrepancies linked to diseases or disorders. For example, in June 2022, BeginNGS, a new program, was initiated by Rady Children’s Institute for Genomic Medicine, a firm based in the US. This endeavor aims at identifying and diagnosing about 400 genetic disorders that have recognizable treatment options before symptoms occur. BeginNGS is working on enhancing genomic sequencing procedures with strategies to increase testing competencies to include roughly 1,000 disorders. The long-term objective is to facilitate screening for around 3.7 million newborns every year, aiming to standardize this practice in hospitals all over the country.
View the full report here:
What Is the Definition of the Prenatal Testing & Newborn Screening Market?
Prenatal testing and newborn screening refer to the combined medical practices aimed at assessing the health of both the fetus during pregnancy and the newborn after birth. Prenatal testing includes various assessments, such as blood tests and ultrasounds, to identify potential genetic or developmental disorders in the fetus. Newborn screening involves conducting tests shortly after birth to detect metabolic, genetic, and endocrine disorders, allowing for early intervention and treatment to improve health outcomes for infants.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3350
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
